Publications

Rogers JM, Setzer RW, Branch S, Chernoff N. 2003. Chemically-induced supernumerary ribs in CD-1 mice: Size distribution and dose-response. Birth Defects Res B 71(1):17–25; doi: 10.1002/bdrb.10055.

Grasty RC, Grey BE, Lau CS, Rogers JM. 2003. Prenatal window of susceptibility to perfluorooctane sulfonate-induced neonatal mortality in the Sprague-Dawley rat. Birth Defects Res B 68(6):465–471; doi: 10.1002/bdrb.10046.

Sarangapani R, Gentry PR, Covington TR, Teeguarden JG, and Clewell HJ. 2003. Evaluation of the potential impact of age- and gender-specific lung morphology and ventilation rate on the dosimetry of vapors. Inhal Toxicol 15(10):987–1016.

Gentry PR, Covington TR, Clewell HJ, Andersen ME. 2003. Application of a physiologically based pharmacokinetic model for reference dose and reference concentration estimation for acetone. J Toxicol Environ Health A 66(23):2209–2225.

Wheeler MW, Bailer AJ. 2003. A simulation study of methods for constructing confidence intervals for bioaccumulation factors. Environ Toxicol Chem 22(4):921-7; doi: 10.1002/etc.5620220433. PMID: 12685730.

Choksi NY, Jahnke GD, St Hilaire C, Shelby MD. 2003. Role of thyroid hormones in human and laboratory animal reproductive health. Birth Defects Res B Develop Reprod Toxicol 68(6):479–491; doi: 10.1210/er.2015-1106.

Clewell H, Crump K, Covington T, Gentry R, Yeager J. A risk assessment for inhaled arsenic based on urinary arsenic concentration using a pharmacokinetic model. Poster presented at the Society of Toxicology Annual Meeting, Salt Lake City, UT, March 2003.

Schuler LJ, Wheeler MW, Bailer AJ, Lydy MJ. 2003. Toxicokinetics of sediment‐sorbed benzo[a]pyrene and hexachlorobiphenyl using the freshwater invertebrates Hyalella azteca, Chironomus tentans, and Lumbriculus variegatus. Environ Toxicol Chem 22(2):439-49; doi: 10.1002/etc.5620220227. PMID: 12558178.

Proctor D, Harris M, Rabbe D. 2002. Chapter 9: A risk assessment of chromium contaminated soils: Ten years of research to characterize the health hazards. In: Human and Ecological Risk Assessment: Theory and Practice, D. Paustenbach (ed.). pp. 485–555.

Haws L. Permitting of hazardous waste combustion facilities in the state of Texas: Human health risks associated with fugitive emissions sources. Presented at the Texas Chemical Council Quarterly Meeting. Houston, TX, August 2002.

Grant RL, Rodriguez R, Hofelt CS, and Haws LC. 2002. Shortcomings in USEPA’s approach for predicting risk due to consumption of animal food products impacted by air emissions from hazardous waste combustion facilities: A case study involving phthalates. Human Ecol Risk Assess 8(5):1137-1154; doi: 10.1080/1080-700291905855.

Haws L. Texas risk reduction program rule-The basics. Question and Answer Forum Panelist. Presented at the Texas Natural Resource Conservation Commission Environmental Trade Fair. Waste Remediation Track, Austin, TX, May 2002.

Roberts SM, Jordan KE, Warren DA, Britt JK, James RC. 2002. Evaluation of the carcinogenicity of 1,1-dichloroethylene (vinylidene chloride). Regul Toxicol Pharmacol 35(1):44-55; doi: 10.1006/rtph.2001.1518.

Haws L. Toxicology and risk assessment resources and practices in the state of Texas. Presented at the USEPA Region 6 States Risk Assessment Roundtable, Dallas, TX, April 2002.

Clewell HJ, Teeguarden J, McDonald T, Sarangapani R, Lawrence G, Covington T, Gentry R, Shipp A. 2002. Review and evaluation of the potential impact of age and gender-specific pharmacokinetic differences on tissue dosimetry. Crit Rev Toxicol 32(5):329–389.

Perry CS. TRRP Rule – The basics part 2: Human health PCLs and look-up tables. TNRCC Environmental Trade Fair presentation and paper, 2002.

Hofelt CS, Honeycutt M, McCoy JT, Haws LC. 2001. Development of a metabolism factor for polycyclic aromatic hydrocarbons for use in multipathway risk assessments for hazardous waste combustion facilities. Reg Toxicol Pharmacol 33(1):60-65; doi: 10.1006/rtph.2000.1438.

Gentry PR, Covington TR, Andersen ME, Clewell HJ. 2002. Application of a physiologically based pharmacokinetic model for isopropanol in the derivation of a reference dose and reference concentration. Regul Toxicol Pharmacol 36:51–68.

Grasty RC, Grey BE, Thibodeaux J, Lau C, Rogers JM. Critical period for increased neonatal mortality induced by perfluorooctane sulfonate (PFOS) in the rat. Society of Toxicology 41st Annual Meeting, Nashville, TN, March 2002.

Strobel HW, Thompson CM, Antonovic L. 2001. Cytochromes P450 in brain: Function and significance. Curr Drug Metabol 2(2):199–214; doi: 10.2174/1389200013338577.